Your account is not claimed yet. You can sign up with ORCID to claim your account.

David Alan Schneider (David A Schneider)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

Biochemistry

Cancers

The Journal of biological chemistry

Proceedings of the National Academy of Sciences of the United States of America

University of Alabama at Birmingham

University of Wisconsin Madison (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Alabama at Birmingham Jan 1o 2016

United States

Associate Dean for Graduate Biomedical Sciences :: Graduate School

Education History

University of Wisconsin Madison Aug 25o 1998 - May 25o 2003

United States

PHD :: Bacteriology

Publications

Catherine E Scull, Guy Twa, Yinfeng Zhang, Naiheng J Yang, Robert N Hunter, Corinne E Augelli-Szafran, David Alan Schneider
Small Molecule RBI2 Disrupts Ribosome Biogenesis through Pre-rRNA Depletion. Cancers 15 (13) (2023)
Adrienne Samani, Rylie M Hightower, Andrea L Reid, Katherine G English, Michael A Lopez, J Scott Doyle, Michael J Conklin, David Alan Schneider, Marcas M Bamman, Jeffrey J Widrick, David K Crossman, Min Xie, David Jee, Eric C Lai, Matthew S Alexander
miR-486 is essential for muscle function and suppresses a dystrophic transcriptome. Life science alliance 5 (9) (2022)
Zachariah I Carter, Ruth Q Jacobs, David Alan Schneider, Aaron L Lucius
Transient-State Kinetic Analysis of the RNA Polymerase II Nucleotide Incorporation Mechanism. Biochemistry (2022)
Zachariah I Carter, Ruth Q Jacobs, David Alan Schneider, Aaron L Lucius
Transient-State Kinetic Analysis of the RNA Polymerase II Nucleotide Incorporation Mechanism. Biochemistry 62 (1) (2022)
Zachariah I Carter, Ruth Q Jacobs, David Alan Schneider, Aaron L Lucius
Transient-State Kinetic Analysis of the RNA Polymerase II Nucleotide Incorporation Mechanism. Biochemistry 62 (1) (2022)
Zachariah I Carter, Ruth Q Jacobs, David Alan Schneider, Aaron L Lucius
Transient-State Kinetic Analysis of the RNA Polymerase II Nucleotide Incorporation Mechanism. Biochemistry 62 (1) (2022)
Ruth Q Jacobs, Kaila B Fuller, Stephanie L Cooper, Zachariah I Carter, Marikki Laiho, Aaron L Lucius, David Alan Schneider
RNA Polymerase I Is Uniquely Vulnerable to the Small-Molecule Inhibitor BMH-21. Cancers 14 (22) (2022)
Shannon E Weeks, Sarah C Kammerud, Brandon J Metge, Heba Allah M Alsheikh, David Alan Schneider, Dongquan Chen, Shi Wei, James A Mobley, Akinyemi I Ojesina, Lalita A Shevde, Rajeev S Samant
Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancer. Cell death & disease 12 (3) (2021)
Catherine E Scull, Zachariah M Ingram, Aaron L Lucius, David Alan Schneider
A Novel Assay for RNA Polymerase I Transcription Elongation Sheds Light on the Evolutionary Divergence of Eukaryotic RNA Polymerases. Biochemistry 58 (16) (2019)
Catherine E Scull, Yinfeng Zhang, Nichole Tower, Lynn Rasmussen, Indira Padmalayam, Robert Hunter, Ling Zhai, Robert Bostwick, David Alan Schneider
Discovery of novel inhibitors of ribosome biogenesis by innovative high throughput screening strategies. The Biochemical journal 476 (15) (2019)
Catherine E Scull, Andrew M Clarke, Aaron L Lucius, David Alan Schneider
Downstream sequence-dependent RNA cleavage and pausing by RNA polymerase I. The Journal of biological chemistry 295 (5) (2019)
Andrew M Clarke, Krysta L Engel, Keith E Giles, Chad M Petit, David Alan Schneider
NETSeq reveals heterogeneous nucleotide incorporation by RNA polymerase I. Proceedings of the National Academy of Sciences of the United States of America 115 (50) (2018)

David Alan Schneider.css-eqlu8i{font-size:small;padding-left:4px;} (David A Schneider)

Publication Activity (10 Years)

Top Topics

Top Venues

David Alan Schneider (David A Schneider)